TPO Levels of Upshaw-Schulman Syndrome
| Patient No. . | Sample . | Date Obtained . | Platelet Count (×104/μL) . | TPO Level (fmol/mL) . |
|---|---|---|---|---|
| 1 | Serum (before infusion) | September 30, 1995 | 6.5* | 0.84† |
| Serum (before infusion) | October 9, 1995 | 2.6* | 1.13† | |
| Serum (before infusion) | October 20, 1995 | 5.5* | 0.87† | |
| 2 | Serum (before infusion) | February 8, 1996 | 1.0* | 1.77† |
| 3 | Serum (before infusion) | April 10, 1996 | 3.1* | 2.94† |
| Serum (before infusion) | April 12, 1996 | 2.2* | 2.81† | |
| Serum (after infusion) | April 17, 1996 | 32.1 | 0.42 | |
| Plasma (used for infusion) | 0.95 | |||
| 4 | Serum (before infusion) | April 15, 1996 | 5.0* | 1.19† |
| Serum (after infusion) | April 24, 1996 | 33.8 | 0.8 | |
| 5 | Serum (before infusion) | March 26, 1996 | 1.5* | 0.66† |
| Serum (after infusion) | April 3, 1996 | 7.1 | 0.42 | |
| Serum (before infusion) | April 10, 1996 | 2.1* | 0.65† | |
| Serum (after infusion) | April 17, 1996 | 17.1 | 0.37 | |
| Mean ± SD | 3.28 ± 1.93* (n = 9) | 1.43 ± 0.89† (n = 9) | ||
| Control 1 (n = 29) | Normal serum | Mean ± SD | 0.79 ± 0.35 | |
| Control 2 (n = 12) | ITP serum | Mean ± SD | 2.04 ± 0.88 | |
| Control 3 (n = 7) | Aplastic serum | Mean ± SD | 18.53 ± 12.37 |
| Patient No. . | Sample . | Date Obtained . | Platelet Count (×104/μL) . | TPO Level (fmol/mL) . |
|---|---|---|---|---|
| 1 | Serum (before infusion) | September 30, 1995 | 6.5* | 0.84† |
| Serum (before infusion) | October 9, 1995 | 2.6* | 1.13† | |
| Serum (before infusion) | October 20, 1995 | 5.5* | 0.87† | |
| 2 | Serum (before infusion) | February 8, 1996 | 1.0* | 1.77† |
| 3 | Serum (before infusion) | April 10, 1996 | 3.1* | 2.94† |
| Serum (before infusion) | April 12, 1996 | 2.2* | 2.81† | |
| Serum (after infusion) | April 17, 1996 | 32.1 | 0.42 | |
| Plasma (used for infusion) | 0.95 | |||
| 4 | Serum (before infusion) | April 15, 1996 | 5.0* | 1.19† |
| Serum (after infusion) | April 24, 1996 | 33.8 | 0.8 | |
| 5 | Serum (before infusion) | March 26, 1996 | 1.5* | 0.66† |
| Serum (after infusion) | April 3, 1996 | 7.1 | 0.42 | |
| Serum (before infusion) | April 10, 1996 | 2.1* | 0.65† | |
| Serum (after infusion) | April 17, 1996 | 17.1 | 0.37 | |
| Mean ± SD | 3.28 ± 1.93* (n = 9) | 1.43 ± 0.89† (n = 9) | ||
| Control 1 (n = 29) | Normal serum | Mean ± SD | 0.79 ± 0.35 | |
| Control 2 (n = 12) | ITP serum | Mean ± SD | 2.04 ± 0.88 | |
| Control 3 (n = 7) | Aplastic serum | Mean ± SD | 18.53 ± 12.37 |